Santhera Pharmaceuticals Holding

from Wikipedia, the free encyclopedia
Santhera Pharmaceuticals Holding AG

logo
legal form Corporation
ISIN CH0027148649
founding 2004
Seat Pratteln , Switzerland
management Thomas Meier
( Management )
Elmar Schnee
( Chairman of the Board )
sales CHF 27.9 million
Branch Pharma
Website www.santhera.com

The Santhera Pharmaceuticals Holding AG , based in Pratteln is on neuromuscular specialized diseases Swiss pharmaceutical company . Founded in 2004 on the Swiss stock exchange since 2006, SIX Swiss Exchange listed .

Field of activity

Santhera focuses on the development and commercialization of drugs for the treatment of serious neuromuscular diseases. The company has a pipeline of various product candidates.

  • Idebenone (Raxone ® / SNT-MC17) receivedapproval from the European Commission for the 28 member statesin September 2015 following positive clinical results in the treatment of Leber's optic atrophy . Since October, Raxone ® has been available in Germany as the first European country. In Canada, Idebenone received conditional marketing authorization for the treatment of Friedreich's ataxia and is marketed there under the product name “Catena”.
  • Santhera's second active ingredient, omigapil (SNT-317) for the treatment of congenital muscular dystrophy , is still in the development phase .
  • In addition, Santhera has the active ingredient fipamezole (JP-1730) and has proven its clinical effectiveness in reducing levodopa- induced dyskinesias in Parkinson's patients .

Web links

Individual evidence

  1. [1] Santhera publishes annual sales 2019 and provides information on progress in the drug pipeline, accessed on January 27, 2020
  2. Santhera Receives European Marketing Authorization for Raxone® in Leber's Hereditary Optic Neuropathy (LHON) , PM from Santhera on September 9, 2015, accessed on October 12, 2015
  3. Santhera launches Raxone® in its first EU market , PM by Santhera from October 1, 2015 (English), accessed on October 12, 2015
  4. a b Products & Pipeline , Santhera website, accessed October 12, 2015